PD-1 as a potential target in cancer therapy
Recently, an improved understanding of the molecular mechanisms governing the host response to tumors has led to the identification of checkpoint signaling pathways involved in limiting the anticancer immune response. One of the most critical checkpoint pathways responsible for mediating tumor-induc...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Blackwell Science Inc
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892798/ |